Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04543461 · ClinicalTrials.gov registry record
American Lung Association (ALA) Lung Health Cohort
A clinical trial of Lung Diseases, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 20
- Study locations
NCT04543461 is a study of Lung Diseases that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 4,000 participants, above the 611-participant average among 31 other Lung Diseases trials with a reported enrollment target (555% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT04543461, a study of Lung Diseases, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.
Conditions Studied
Study Locations (20)
Illinois
- University of Illinois at Chicago - Chicago
- Northwestern University - Chicago
- Rush Universtiy - Chicago
- University of Chicago - Chicago
California
- University of California, Los Angeles - Los Angeles
- University of California, San Francisco - San Francisco
Colorado
- University of Colorado - Aurora
- National Jewish Health - Denver
Florida
- Nemours Children's Jacksonville - Jacksonville
- University of Florida, Jacksonville - Jacksonville
New York
- Presbyterian Brooklyn Methodist Hospital - Brooklyn
- New York Medical College - Hawthorne
Alabama
- University Of Alabama - Birmingham
Arizona
- University of Arizona-Tuscon - Tucson
Indiana
- St. Vincent's Health System - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2021-10-29 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04543461
The ClinicalTrials.gov registry entry for NCT04543461 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 611-participant average among 31 other Lung Diseases trials with a reported enrollment target (555% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT04543461 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Illinois, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04543461 about?
NCT04543461 is a clinical study titled "American Lung Association (ALA) Lung Health Cohort". The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health...
What is the current status of trial NCT04543461?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2021-10-29. Estimated completion is 2026-09.
What conditions does trial NCT04543461 study?
This clinical trial studies the following conditions: Lung Diseases.
Who is sponsoring clinical trial NCT04543461?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04543461 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Data Collection Using Eko Digital Devices in a Clinical Setting
RECRUITING
-
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING · Phase 2
-
Deep Functional Phenotyping of the ALA Lung Health Cohort
RECRUITING
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.